French Sanofi and Russian Nanolec have signed an agreement on local production of combined vaccine Pentaxim ®, providing childhood protection against five infections: diphtheria, tetanus, pertussis, polio, hemophilus influenza type b.
At the first stage local operations will only include packaging. Locally packaged Pentaxim® will be launched at the end of this year. Full cycle production will be launched later (the earliest in 2019). Then it will be possible to discuss the issue of the drug localization in this country and inclusion of the vaccine into the National vaccination schedule.